Literature DB >> 6148758

Stimulation of beta-adrenergic receptors and spontaneous motor activity in mice.

P L Goldschmidt, H Frances, P Simon.   

Abstract

The effects of 3 beta-adrenergic agonists (clenbuterol, isoproterenol and salbutamol) on the spontaneous motor activity of mice were studied. The present research indicated that motor activity was significantly decreased 30 minutes after IP injection of either clenbuterol (0.06 mg/kg), isoproterenol (0.5 mg/kg) or salbutamol (2 mg/kg). Hypomotility induced by clenbuterol was also significantly antagonized by propranolol in doses ranging from 1 to 8 mg/kg and by penbutolol in doses from 0.03 to 0.5 mg/kg. However, practolol, which does not cross the blood brain barrier, did not antagonize the effect of clenbuterol. Therefore, it may be hypothesized that beta adrenergic agonists decrease motor activity by a central mechanism. It was also found that tachyphylaxis or resistance to treatment, observed in cardiovascular and bronchopulmonary systems with beta-adrenergic agonists, developed after 7 injections of clenbuterol (0.25 mg/kg IP, twice daily) in the behavioral model of spontaneous motor activity in mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148758     DOI: 10.1016/0091-3057(84)90210-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  6 in total

1.  Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity.

Authors:  Jodi E Gresack; Victoria B Risbrough
Journal:  Int J Neuropsychopharmacol       Date:  2010-12-21       Impact factor: 5.176

2.  Effects of salbutamol upon performance on an operant screen for antidepressants.

Authors:  R T Dunn; J B Richards; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Tolerance to or facilitation of pharmacological effects induced by chronic treatment with the beta-adrenergic stimulant clenbuterol.

Authors:  H Francès; B Diquet; P Goldschmidt; P Simon
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Chronic beta-adrenergic stimulation increases in mice the sensitivity to methysergide and the number of cerebral high affinity serotonin binding sites (5-HT-1).

Authors:  H Frances; C Bulach; P Simon; M Fillion; G Fillion
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Beta2-adrenoceptor agonists alleviate neuropathic allodynia in mice after chronic treatment.

Authors:  Nada Choucair-Jaafar; Ipek Yalcin; Jean-Luc Rodeau; Elisabeth Waltisperger; Marie-José Freund-Mercier; Michel Barrot
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

6.  Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.

Authors:  Nazanin Ghazanfari; Marco Morsch; Nigel Tse; Stephen W Reddel; William D Phillips
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.